M4MM
Google Launches Limited Test of Cannabis Advertising on Its Search Platform in Canada
TORONTO – Google has started a restricted trial allowing select Canadian Cannabis companies to place ads on its search engine, marking a cautious step toward easing long-standing prohibitions on such promotions. The initiative, which went ...
Ricky Williams Urges Trump to Advance Cannabis Rescheduling Despite Policy Pushback
WASHINGTON – Retired NFL player Ricky Williams has renewed calls for President Trump to reclassify Cannabis to Schedule III, positioning the change as vital for medical access and economic stability in an op-ed that highlights ...
Cannabis Stocks Climb 79% in a Month, But Path to Past Highs Remains Uncertain
LOS ANGELES – Publicly traded Cannabis companies have seen sharp gains recently, with the AdvisorShares Pure US Cannabis ETF (MSOS) climbing about 79% over the past month. This rally prompts questions about sustainability and potential ...
New Zealand Approves Psilocybin for Medicinal Use
LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...
Psyence Group Inc. Announces C$600,000 Private Share Offering
LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on nature-derived psilocybin for mental health and palliative care, has announced a non-brokered private placement to raise up to C$600,000. The offering, detailed in a news ...
Texas Governor Expands Medical Cannabis Program, Vetoes THC Ban
LOS ANGELES— Texas Governor Greg Abbott has signed House Bill 46 into law, significantly expanding the state’s limited medical cannabis program, while vetoing Senate Bill 3, which aimed to ban hemp‑derived THC products—including delta‑8 gummies, ...
Method Man and Zamnesia Partner to Launch Eight TICAL Cannabis Seeds in U.S. and Europe
LOS ANGELES- Zamnesia—a European online retailer specializing in cannabis seeds—has partnered with Method Man’s cannabis brand, TICAL, to launch eight exclusive premium seeds across the U.S. and Europe. The collaboration, announced in early June 2025, ...
Google Launches Limited Test of Cannabis Advertising on Its Search Platform in Canada
TORONTO – Google has started a restricted trial allowing select Canadian Cannabis companies to place ads on its search engine, marking a cautious step toward easing long-standing prohibitions on such promotions. The initiative, which went ...
Ricky Williams Urges Trump to Advance Cannabis Rescheduling Despite Policy Pushback
WASHINGTON – Retired NFL player Ricky Williams has renewed calls for President Trump to reclassify Cannabis to Schedule III, positioning the change as vital for medical access and economic stability in an op-ed that highlights ...
Cannabis Stocks Climb 79% in a Month, But Path to Past Highs Remains Uncertain
LOS ANGELES – Publicly traded Cannabis companies have seen sharp gains recently, with the AdvisorShares Pure US Cannabis ETF (MSOS) climbing about 79% over the past month. This rally prompts questions about sustainability and potential ...
Cresco Labs Reports Q2 Results Amid Expansion Efforts
LOS ANGELES— Cresco Labs, a Chicago-based cannabis company, disclosed a 9% decline in revenues for the second quarter ended June 30, compared to the same timeframe last year. However, the company registered a modest quarter-on-quarter ...
Ohio Projects Significant Tax Revenues from Potential Cannabis Legalization
LOS ANGELES— Ohio might experience a significant influx in tax revenue from adult-use cannabis sales, estimated between $276.2 million to $403.6 million annually by the fifth year, should voters approve a prospective legalization measure this ...
atai Life Sciences Releases Promising Results from PCN-101 Phase 1 Study, Offering Potential for Home-Based Use
LOS ANGELES-- atai Life Sciences (NASDAQ: ATAI), a pioneering biotech company, has reported encouraging results from its Phase 1 investigation into the subcutaneous administration of PCN-101 (R-ketamine), facilitated through its subsidiary, Perception Neuroscience. The trial's ...
GrowGeneration Corp Reports Mixed Financial Performance Amid Challenging Cannabis Landscape
LOS ANGELES — GrowGeneration Corp., a specialty hydroponic and organic garden center chain with 62 branches across 18 states, announced its financial performance for the second quarter ending June 30, 2023. Key Takeaways: Net Sales: ...
Green Thumb Industries Reports Q2 2023 Financial Performance; Revenue Grows Sequentially
LOS ANGELES— Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), one of the prominent national cannabis consumer packaged goods companies and the proprietor of RISE Dispensaries, revealed its Q2 financial results for the period ending ...
MyMD Pharmaceuticals Receives FDA Approval to Proceed with Investigational Rheumatoid Arthritis Drug
BALTIMORE – MyMD Pharmaceuticals, Inc. announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) Application to study the safety and effectiveness of the oral TNF-α ...
South Dakota Takes Steps Towards Legalization of Cannabis: New Initiative Awaits Public Comment
LOS ANGELES-- South Dakota's path to legalizing cannabis took a notable step forward, as the state's Attorney General Marty Jackley (R) has officially released a draft summary of an initiative to legalize the substance. The ...
MindMed Partners with K2 HealthVentures in $50 Million Credit Facility for Brain Health Research
NEW YORK — Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company focused on developing innovative solutions for brain health disorders, announced today the signing of a senior secured credit facility with K2 HealthVentures, a leading ...
Columbia Care Reports Q2 Earnings: Revenue Remains Steady as Cost-Cutting Efforts Show Results
NEW YORK — Columbia Care Inc., a player in the cannabis industry, released its financial results for the second quarter ending June 30, 2023, showcasing resilience amid complex market conditions. The numbers reveal slight shifts ...
Glass House Brands Reports Record Second Quarter 2023 Financial Results
LOS ANGELES-- Glass House Brands Inc., a vertically integrated cannabis companies in the U.S., reported its financial results for Q2 2023, ending June 30. The figures reveal a record-breaking quarter for the company, with revenue ...
Michigan Poised to Become a $3 Billion Cannabis Market; July Sales Record Set
LOS ANGELES —Michigan's cannabis market is booming, on pace to reach a significant milestone this year, potentially becoming the nation's second $3-billion market. Licensed dispensaries reported record sales of $276.7 million in July 2023, with ...
Alabama Medical Cannabis Commission Revamps Licensing, Leaving Verano Holdings Out
LOS ANGELES-- The Alabama Medical Cannabis Commission has overhauled its initial round of business licensing, with some of the original winners, including Verano Holdings Inc., ending up on the losing side. The reshuffling has led ...
Mind Medicine Partners with Catalent for Innovative Psychedelic-Based Anxiety Treatment
NEW YORK — Mind Medicine Inc., known as MindMed, has secured a licensing agreement with Catalent to utilize its proprietary Zydis orally disintegrating tablet (ODT) technology for the development of a groundbreaking psychedelic-based anxiety treatment, ...
New Hampshire to Explore State-Run Cannabis Sales Through Newly Signed Bill
LOS ANGELES- Governor Chris Sununu (R) of New Hampshire, a known opponent of adult-use cannabis legalization, signed a bill on Tuesday to create a commission to study the possibility of selling cannabis through state-owned shops. ...
Cronos Group Reports Q2 2023 Financial Results, Announces Strategic Shift Amid Market Challenges
NEW YORK — Cronos Group Inc. released its financial results for the second quarter of 2023, revealing a net revenue of $19.0 million, an 11.9% decrease from the same period in 2022. The decline has ...
